Darjee R, Gibb A P
Department of Medical Microbiology, Medical School, Edinburgh, Canada.
J Clin Pathol. 1993 Dec;46(12):1116-9. doi: 10.1136/jcp.46.12.1116.
To determine if there was an increase in antibody titre to Streptococcus bovis in patients with colonic cancer, and if this might be a useful marker of the presence for colonic cancer.
Serum samples from 16 patients and 16 age matched controls were tested by immunoblot and enzyme linked immunosorbent assay (ELISA) against antigen preparations from two strains of S bovis and one strain of Enterococcus faecalis.
No distinction between cancer patients and controls could be made using immunoblots. ELISA did show an increase in antibodies to S bovis, but there was a greater increase in antibodies to E faecalis. The increase in antibody titres was greatest with antigens which had been treated with periodate, and was therefore thought not to be caused by antibody to the shared group D carbohydrate antigen.
It may be possible to construct a test for the detection of colonic cancer based on the detection of antibody to S bovis or E faecalis, though considerable further development of this concept is required.
确定结肠癌患者中牛链球菌抗体滴度是否升高,以及这是否可能是结肠癌存在的有用标志物。
采用免疫印迹法和酶联免疫吸附测定法(ELISA),对16例患者和16例年龄匹配的对照者的血清样本进行检测,检测对象为两种牛链球菌菌株和一种粪肠球菌菌株的抗原制剂。
使用免疫印迹法无法区分癌症患者和对照者。ELISA确实显示牛链球菌抗体增加,但粪肠球菌抗体增加幅度更大。用高碘酸盐处理过的抗原,其抗体滴度增加最大,因此认为这不是由共享的D组碳水化合物抗原抗体引起的。
基于检测牛链球菌或粪肠球菌抗体,有可能构建一种检测结肠癌的试验,不过这一概念需要进一步大力发展。